Cocrystal Pharma, Inc.
COCP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$17,504 | -$17,984 | -$38,837 | -$14,185 |
| Dep. & Amort. | $126 | -$1,388 | $388 | $190 |
| Deferred Tax | $0 | $0 | $0 | -$49 |
| Stock-Based Comp. | $643 | $801 | $855 | $724 |
| Change in WC | $140 | $2,342 | -$2,712 | $796 |
| Other Non-Cash | $110 | $1,563 | $18,871 | -$195 |
| Operating Cash Flow | -$16,485 | -$14,666 | -$21,435 | -$12,719 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8 | -$118 | -$74 | -$52 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$8 | -$118 | -$74 | -$52 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$7 | -$27 | -$39 |
| Stock Issued | $0 | $4,000 | $0 | $38,505 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $3,993 | -$27 | $38,466 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$16,493 | -$10,791 | -$21,536 | $25,695 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26,428 | $37,219 | $58,755 | $33,060 |
| End Cash | $9,935 | $26,428 | $37,219 | $58,755 |
| Free Cash Flow | -$16,493 | -$14,784 | -$21,509 | -$12,771 |